Shire Pharma Canada ULC ("Shire Canada") is a wholly owned subsidiary of Shire plc, a global specialty biopharmaceutical company that works closely with specialist physicians to develop and market medicines that improve the quality of life for patients, their families and caregivers.

Shire Canada focuses on attention deficit hyperactivity disorder (ADHD), rare diseases, as well as gastrointestinal and renal diseases.

In Canada, Shire is a proud member of Innovative Medecines Canada (previously known as Rx&D) and of BIOTECanada.

Our Canadian offices are located in the Greater Montreal area, in Québec:

2250 Alfred-Nobel Blvd, Suite 500
Saint-Laurent, QC H4S 2C9
Tel: +1 514 787 2300
Fax: +1 514 787 2427

Site Image